Off-label treatments refer to the use of pharmaceutical drugs for an unapproved indication, dosage, or patient population. This practice is common in the field of oncology due to the complex and heterogeneous nature of cancer. Oncologists often resort to off-label treatments when standard therapies are ineffective or when treating rare cancer types for which approved therapies are limited.
